IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PRISCILLA CHOW

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1871024745
CMS profile
11303625
Location
NEWARK, NJ

General Payments · PY2021–2024

$6,019.74

  • Reported across 183 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,377.41

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Internal Medicine NJ All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,278.42 50
Education $98.99 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $298.46 8
GlaxoSmithKline, LLC. $262.68 13
Actelion Pharmaceuticals US, Inc. $190.76 7
Acerta Pharma LLC $178.20 11
Regeneron Healthcare Solutions, Inc. $124.98 1
Mylan Specialty L.P. $121.32 1
GENZYME CORPORATION $78.04 4
Gilead Sciences, Inc. $47.96 2
UCB, Inc. $28.12 1
United Therapeutics Corporation $16.99 1
Insmed, Inc. $15.95 1
Electromed, Inc. $13.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $143.38 2
PY2022 $1,808.59 57
PY2023 $2,690.36 73
PY2024 $1,377.41 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $16.94 01/31/2024 Food and Beverage Undisputed 01/23/2026 1078901067 CMS
Actelion Pharmaceuticals US, Inc. $11.28 02/28/2024 Food and Beverage Undisputed 01/23/2026 1078901217 CMS
Actelion Pharmaceuticals US, Inc. $16.99 04/17/2024 Food and Beverage Undisputed 01/23/2026 1078901211 CMS
Actelion Pharmaceuticals US, Inc. $16.93 05/23/2024 Food and Beverage Undisputed 01/23/2026 1078901013 CMS
Actelion Pharmaceuticals US, Inc. $98.99 05/23/2024 Education Undisputed 01/23/2026 1078901195 CMS
Actelion Pharmaceuticals US, Inc. $12.99 07/10/2024 Food and Beverage Undisputed 01/23/2026 1078901021 CMS
Actelion Pharmaceuticals US, Inc. $16.64 09/18/2024 Food and Beverage Undisputed 01/23/2026 1078901039 CMS
AstraZeneca Pharmaceuticals LP $16.61 01/25/2024 Food and Beverage Undisputed 01/23/2026 1104411589 CMS
AstraZeneca Pharmaceuticals LP $15.24 02/12/2024 Food and Beverage Undisputed 01/23/2026 1105449047 CMS
AstraZeneca Pharmaceuticals LP $16.23 02/26/2024 Food and Beverage Undisputed 01/23/2026 1105861732 CMS
AstraZeneca Pharmaceuticals LP $16.48 03/07/2024 Food and Beverage Undisputed 01/23/2026 1104700865 CMS
AstraZeneca Pharmaceuticals LP $15.71 04/08/2024 Food and Beverage Undisputed 01/23/2026 1104471002 CMS
AstraZeneca Pharmaceuticals LP $16.95 04/09/2024 Food and Beverage Undisputed 01/23/2026 1104760170 CMS
AstraZeneca Pharmaceuticals LP $16.04 05/02/2024 Food and Beverage Undisputed 01/23/2026 1105716836 CMS
AstraZeneca Pharmaceuticals LP $15.37 05/06/2024 Food and Beverage Undisputed 01/23/2026 1104588254 CMS
AstraZeneca Pharmaceuticals LP $14.88 07/01/2024 Food and Beverage Undisputed 01/23/2026 1104429089 CMS
AstraZeneca Pharmaceuticals LP $18.98 08/21/2024 Food and Beverage Undisputed 01/23/2026 1104633505 CMS
AstraZeneca Pharmaceuticals LP $15.71 09/16/2024 Food and Beverage Undisputed 01/23/2026 1104745551 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.70 01/25/2024 Food and Beverage Undisputed 01/23/2026 1118199395 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.64 02/15/2024 Food and Beverage Undisputed 01/23/2026 1118199415 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.38 03/21/2024 Food and Beverage Undisputed 01/23/2026 1118199411 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.99 04/30/2024 Food and Beverage Undisputed 01/23/2026 1118199399 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $99.55 07/16/2024 Food and Beverage Undisputed 01/23/2026 1118199403 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.56 08/14/2024 Food and Beverage Undisputed 01/23/2026 1118199391 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.93 09/26/2024 Food and Beverage Undisputed 01/23/2026 1118199387 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $101.71 10/01/2024 Food and Beverage Undisputed 01/23/2026 1118199407 CMS
Electromed, Inc. $13.95 09/25/2024 Food and Beverage Undisputed 01/23/2026 1137884081 CMS
GENZYME CORPORATION $15.69 02/27/2024 Food and Beverage Undisputed 01/23/2026 1140003059 CMS
GENZYME CORPORATION $18.61 03/12/2024 Food and Beverage Undisputed 01/23/2026 1140003057 CMS
GENZYME CORPORATION $17.99 10/07/2024 Food and Beverage Undisputed 01/23/2026 1140003063 CMS
GENZYME CORPORATION $25.75 11/13/2024 Food and Beverage Undisputed 01/23/2026 1140003101 CMS
Gilead Sciences, Inc. $21.96 09/19/2024 Food and Beverage Undisputed 01/23/2026 1133637321 CMS
Gilead Sciences, Inc. $26.00 10/10/2024 Food and Beverage Undisputed 01/23/2026 1133637323 CMS
GlaxoSmithKline, LLC. $1.11 01/16/2024 Food and Beverage Undisputed 01/23/2026 1116315236 CMS
GlaxoSmithKline, LLC. $14.50 01/16/2024 Food and Beverage Undisputed 01/23/2026 1116671342 CMS
GlaxoSmithKline, LLC. $122.43 01/30/2024 Food and Beverage Undisputed 01/23/2026 1116683155 CMS
GlaxoSmithKline, LLC. $15.94 02/14/2024 Food and Beverage Undisputed 01/23/2026 1116445106 CMS
GlaxoSmithKline, LLC. $16.02 03/11/2024 Food and Beverage Undisputed 01/23/2026 1116475374 CMS
GlaxoSmithKline, LLC. $18.04 03/19/2024 Food and Beverage Undisputed 01/23/2026 1116296401 CMS
GlaxoSmithKline, LLC. $15.94 04/27/2024 Food and Beverage Undisputed 01/23/2026 1116668086 CMS
GlaxoSmithKline, LLC. $0.71 04/29/2024 Food and Beverage Undisputed 01/23/2026 1116403505 CMS
GlaxoSmithKline, LLC. $7.36 06/03/2024 Food and Beverage Undisputed 01/23/2026 1116721835 CMS
GlaxoSmithKline, LLC. $15.93 08/27/2024 Food and Beverage Undisputed 01/23/2026 1116068616 CMS
GlaxoSmithKline, LLC. $1.03 08/27/2024 Food and Beverage Undisputed 01/23/2026 1116425439 CMS
GlaxoSmithKline, LLC. $17.81 10/02/2024 Food and Beverage Undisputed 01/23/2026 1116088556 CMS
GlaxoSmithKline, LLC. $15.86 11/20/2024 Food and Beverage Undisputed 01/23/2026 1116069513 CMS
Insmed, Inc. $15.95 04/16/2024 Food and Beverage Undisputed 01/23/2026 1089577136 CMS
Mylan Specialty L.P. $121.32 05/01/2024 Food and Beverage Undisputed 01/23/2026 1147285710 CMS
Regeneron Healthcare Solutions, Inc. $124.98 03/07/2024 Food and Beverage Undisputed 01/23/2026 1114025530 CMS
UCB, Inc. $28.12 12/18/2024 Food and Beverage Undisputed 01/23/2026 1143098269 CMS
United Therapeutics Corporation $16.99 05/07/2024 Food and Beverage Undisputed 01/23/2026 1149453028 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.